---
tags:
    - dm
    - obgyn
created: 2021-02-05T02:45:32.587Z
modified: 2021-02-05T07:14:48.013Z
---
# Pregestational Diabetes Mellitus

> ACOG Practice Bulletin 201 Pregestational Diabetes Mellitus

- [Pregestational Diabetes Mellitus](#pregestational-diabetes-mellitus)
  - [Definition](#definition)
  - [Management](#management)
  - [Maternal Morbidity](#maternal-morbidity)
  - [Diabetic Ketoacidosis During Pregnancy](#diabetic-ketoacidosis-during-pregnancy)
    - [Common Risk factors](#common-risk-factors)
    - [Symptoms](#symptoms)
    - [Lab](#lab)
    - [Management of DKA](#management-of-dka)
  - [Perinatal Morbidity and Mortality](#perinatal-morbidity-and-mortality)
  - [Obstetric Complications](#obstetric-complications)
  - [Counseling and Management](#counseling-and-management)

## Definition

- U/D T1DM, T2DM
- 1st- or early 2nd-trimester
  - HbA1C >= 6.5%
  - FPG >= 126 mg/dL
  - 75-g 2-h OGTT >= 200 mg/dL

## Management

Goal: Maintained near physiologic glucose level

- Diet
  - complex carb
- Exercise
- Medical therapy
  - Insulin  lispro, aspart > Regular insulin
    - more rapid onset
    - fewer hypoglycemic episodes
  - 15 g of carb if hypoglycemia
    - Glucagon administration for severe hypoglycemia and loss of conciousness
- SMBG
  - q1-2wk in 1st-trimester
  - q1wk after GA 24-28 wk
  - FPG <=95, 1-hr PP <=140, 2-hr PP <= 120
  - During night >= 60
  - Mean CPG 100 mg/dL
  - Urine ketone if glucose > 200 mg/dL
- Eye examination in 1st-trimester + F/U
- Baseline Cr, UPCR, 24-hr Urine protein + F/U
- Baseline EKG (esp. longstanding DM)

## Maternal Morbidity

- Diabetic retinopathy
  - Proliferative retinopathy -> PRP before pregnant
  - Commonly progress in pregnancy
- Diabetic nephropathy
  - if preexisting -> significantly higher risk for
    - hypertensive d/o
    - uteroplacental insuf
    - iatrogenic preterm birth
- Chronic hypertension
  - increases risk of
    - preeclampsia
    - uteroplacental insuf
    - stillbirth
  - if ACEI, ARB -> switch anti-HT when pregnant
- Risk factor for acute MI
  - Preexisting CAD maybe C/I to pregnancy
- Diabetic neuropathy
  - Autonomic neuropathy may -> gastroparesis
    - if hyperemesis
      - may require TPN
      - increase risk of hypoglycemia
      - metoclopramide, prokinetic can be used

## Diabetic Ketoacidosis During Pregnancy

common in T1DM > T2DM

### Common Risk factors

- New onset DM
- Infections
  - Influenza
  - UTI
- Poor compliance
- Insulin pump failure
- Drug
  - Beta-mimetic tocoltic dru
  - Antenatal corticosteroids

### Symptoms

- Abd pain
- N/V
- Altered sensorium

### Lab

- Arterial pH < 7.3
- HCO3- < 15 mEq/L
- Elevated anion gap
- Positive serum ketones
- EFM
  - minimal variability
  - late deceralation if UC
- F/U CPG q1h, Electrolyte, ketone q1-2h if possible

### Management of DKA

- IV Fluids
  - NSS 1-2 L/hr for first hr
  - NSS 250-500 mL/hr depends on hydration state (8 hr)
  - If HyperNa -> 0.45% NaCl
  - When Serum glucose reach 200 mg/dL -> 5%DN/2 150-250 mL/hr  
  - After 8 hr, 0.45% NaCl 125 mL/hr
- Potassium
  - keep UOP ~50 mL/hr
  - If K < 3.3, hold insulin, 20-30 mEq K/hr until K > 3.3
  - If 3.3 < K < 5.3, 20-30 mEq K/1 L of IV, keep K 4-5
  - If K > 5.3, do not give K, check K q2hr
- Regular Insulin IV
  - Consider load 0.1-0.2 units/kg depends on plasma glucose
  - drip 0.1 units/kg/hr
  - If serum glucose fall <50 mg/dL in 1 hr, double dose
  - When serum glucose reach 200 mg/dL, reduce rate to 0.05-0.1 units/kg/hr
  - Keep serum glucose 100-150 until resolution
- Bicarbonate
  - pH 6.9-7.0 -> 7.5% NaHCO3 50 mL + น้ำ 200mL + 10 mEq KCl drip in 1 hr, repeat NaHCO3 q2hr until pH=7.0
  - pH <6.9 -> 7.5% NaHCO3 100 mL + น้ำ 400 mL + 20 mEq KCl drip in 2 hr, repeat NaHCO3 q2hr until pH=7.0

## Perinatal Morbidity and Mortality

- poor prepregnancy glucose control -> increased rate of
  - congenital malformation
  - spontaneous abortion
- Hyperglyceimaa during organogenesis (5-8wk after LMP)
  - abnormal development
- Elevated HbA1C -> higher rate anomalies, stillbirth, macrosomia
- Diffusion of glucose across placenta -> transient fetal hyperglycemia -> stimulation to fetal pancreatic beta cells -> fetal hyperinsulinemia
  - insulin = potent growth hormone ->
    - excessive fetal growth (esp. adipose tissue)
    - weight more than 4000 g
    - disproportionate conc of fact around shoulder and chest -> risk of shoulder dystocia at vaginal delivery
- Profound hypoglycemia -> higher rate of
  - RDS
  - Polycythemia
  - Organomegaly
  - Electrolyte disturbancees
  - Hyperbilirubinemia

## Obstetric Complications

- increased rate of
  - Primary C/S
  - Spontaneous preterm labor
  - Polyhydramnios -> preterm labor
- HbA1C < 7% -> better obstetric outcomes

Pregnancy with T1DM w/o nephropathy -> 15-20% preeclampsia  
w/ nephropathy -> 50% preeclampsia

## Counseling and Management

- Prepregnancy visit
  - Counsel potential complications
    - preeclampsia
    - hyperglycemia
    - worsening diabetic retinopathy, nephropathy
    - preterm delivery
    - mode of delivery
    - fetal anomalies
    - fetal macrosomia
    - neonatal complications
  - Evaluate baseline
    - hypertension
    - nephropathy
    - retinopathy
    - CVD
  - Contraception if not planning pregnancy
  - Optimize HbA1C (<6%)
  - Plan to increased folic acid when attempt to pregnant
- 1st-trimester
  - Lab
    - HbA1C
    - TSH
    - 24-hr urine protein
    - EKG
  - Evaluation by
    - Ophthalmologist
    - Dietitian
    - Possibly
      - Endocrinologist
      - Cardiologist
      - Nephrologist
- 2nd-trimester
  - low-dose aspirin GA 12-28 wk (optimal <16 wk)
  - U/S with detailed anatomical survery
  - Consider fetal echocardiography
- 3rd-trimester
  - Evaluate fetal growth
  - Start low-dose aspirin by GA 28 wk if not started
  - Fetal monitoring
- Delivery
  - EFW >=4500 -> consider C/S
  - w/o vascular complications, well controled- blood shugar -> deliver at 39 0/7 - 39 6/7 GA
  - w/ vascular complicationsor poorly controlled blood glucosel, delivery at GA 36/07 - 38 6/7 wk
